Lamotrigina Eg

Lamotrigine, the active ingredient in Lamotrigina Eg, is an anticonvulsant presented as an oral tablet for oral use. It treats epilepsy, bipolar disorder, and migraine prophylaxis in patients as prescribed by a healthcare professional.

GNH USA supplies Lamotrigina Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is used in several neurological and psychiatric conditions where abnormal neuronal excitability is a key factor. - Epilepsy: reduces seizure frequency in patients with focal or generalized seizures. - Bipolar disorder: helps stabilize mood and prevent depressive and manic episodes. - Migraine prophylaxis: decreases the frequency of migraine attacks when used as preventive therapy.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach upset or urge to vomit. - Rash: skin redness or itching, often mild. - Blurred vision: temporary visual disturbances. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Blood dyscrasias: such as agranulocytosis or aplastic anemia. - Severe hepatic injury: marked liver enzyme elevation. - Suicidal ideation: emergence of thoughts of self‑harm.

When prescribing lamotrigine, clinicians should consider several safety measures. - Dose titration: start low and increase gradually to lower rash risk. - Skin reactions: monitor for any rash and discontinue if severe. - Hepatic function: assess liver status before initiation and during therapy. - Concomitant valproate: avoid rapid dose escalation due to increased lamotrigine levels. - Pregnancy: discuss potential risks with the prescriber before use. - Store at room temperature: keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising toxicity risk. - Carbamazepine: significantly reduces lamotrigine concentrations, potentially decreasing efficacy. - Oral contraceptives: increase lamotrigine clearance, possibly reducing therapeutic effect.

Moderate Interactions (Monitor Closely): - Phenobarbital: lowers lamotrigine levels, may require dose adjustment. - Phenytoin: decreases lamotrigine concentration, monitor seizure control. - Rifampin: induces metabolism, leading to reduced lamotrigine exposure.